Molecular diagnosis is a pillar of precision medicine. Capable of predicting treatment effects through a comprehensive analysis of the patient's condition, the approach allows optimal drug selection to slash time and cost for recovery.

Furthermore, periodic screening for biomarkers could detect disease in the early stages, giving much-needed time for prompt treatment that could improve the survival rate of patients. And more importantly, accurate screening helps clinical drug development. These advantages prove how important molecular diagnostics are to modern society.

Taiwan is highly active in the area of in-vitro diagnostics research and development, having launched numerous tests for the world's most popular diseases. In this article, we list 9 companies that will give a quick snapshot of the island's molecular diagnostics industry.